Expert Analysis
Treatment of HBV
Source: CCO Independent Conference Coverage of the 2004 Annual Meeting of The American Association for the Study of Liver Diseases*
*CCO is an independent medical education company that provides state-of-the-art
medical information to healthcare professionals through conference coverage and other educational programs.
|
|
Learning Objectives
Upon completion of this activity, participants should be able to:
Describe the results of recent studies of antiviral agents for the treatment of chronic hepatitis B, including adefovir dipivoxil, entecavir, telbivudine, and lamivudine as well as peginterferon and standard interferon Review approaches for avoiding the development of drug resistance during treatment of chronic hepatitis B, and for treating patients infected with lamivudine-resistant HBV Discuss the prevention of vertical transmission of HBV
Earn CME credit by reading the expert analysis and commentary on Treatment of HBV.
Topics covered include:
-
Peginterferon
-
Entecavir
-
Entecavir Resistance and Lamivudine Resistance
-
Emtricitabine
-
Lamivudine and Vertical Transmission
-
Lamivudine
-
Other Agents: Adefovir, Telbivudine, and Clevudine
-
Miscellaneous Topics
|
Disclaimer: The materials published on the Clinical Care Options
Web site reflect the views of the reviewers or authors of the
CCO
material, not those of Clinical Care Options, LLC, the CME provider,
or the companies providing educational grants. The materials may
discuss uses and dosages for therapeutic products that have not been
approved by the United States Food and Drug Administration. A qualified
healthcare professional should be consulted before using any therapeutic
product discussed. Readers should verify all information and data before
treating patients or using any therapies described in these materials.
|
Jointly sponsored by Northwestern University’s Feinberg School of Medicine and Clinical Care Options, LLC.
Pharmacist and nursing credit provided through the cosponsorship of Medical Education Collaborative and Clinical Care Options, LLC.
Contact Info
Educational grants provided by:
Educational grants support only the CME-certified components of this program.
CCO Resources
CCO Expert Recap of data from the 2004 Annual Meeting of the American Association for the Study of Liver Diseases
|
|